Sheng-Hong Tseng

452 total citations
12 papers, 362 citations indexed

About

Sheng-Hong Tseng is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Sheng-Hong Tseng has authored 12 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Sheng-Hong Tseng's work include CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Research and Treatments (2 papers). Sheng-Hong Tseng is often cited by papers focused on CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Research and Treatments (2 papers). Sheng-Hong Tseng collaborates with scholars based in Taiwan and United States. Sheng-Hong Tseng's co-authors include Yun Chen, Yen‐Hao Su, Hsin‐Yi Huang, M S Bobola, John R. Silber, A. Blank, Swei-Ming Lin, Lih‐Hwa Hwang, Chia‐Tung Shun and Chia‐Ling Hsieh and has published in prestigious journals such as Clinical Cancer Research, Neuroscience Letters and Lung Cancer.

In The Last Decade

Sheng-Hong Tseng

12 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng-Hong Tseng Taiwan 8 192 100 84 81 50 12 362
Jianbing Hou China 13 408 2.1× 96 1.0× 25 0.3× 154 1.9× 148 3.0× 24 629
Dianming Jiang China 11 208 1.1× 36 0.4× 29 0.3× 65 0.8× 55 1.1× 16 348
Hala Elnakat Thomas United States 9 312 1.6× 12 0.1× 31 0.4× 68 0.8× 110 2.2× 9 460
V. Bumbaširević Serbia 8 186 1.0× 21 0.2× 16 0.2× 59 0.7× 59 1.2× 11 363
Xuqin Xie China 9 267 1.4× 24 0.2× 28 0.3× 68 0.8× 128 2.6× 10 467
Ok‐Seon Kwon South Korea 11 219 1.1× 28 0.3× 16 0.2× 64 0.8× 78 1.6× 21 320
Yannasittha Jiramongkol United Kingdom 8 261 1.4× 31 0.3× 24 0.3× 59 0.7× 99 2.0× 12 373
Wing‐Keung Chu Taiwan 10 162 0.8× 53 0.5× 7 0.1× 89 1.1× 55 1.1× 17 351
André Wendindondé Nana Taiwan 12 158 0.8× 24 0.2× 21 0.3× 137 1.7× 85 1.7× 12 357

Countries citing papers authored by Sheng-Hong Tseng

Since Specialization
Citations

This map shows the geographic impact of Sheng-Hong Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng-Hong Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng-Hong Tseng more than expected).

Fields of papers citing papers by Sheng-Hong Tseng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng-Hong Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng-Hong Tseng. The network helps show where Sheng-Hong Tseng may publish in the future.

Co-authorship network of co-authors of Sheng-Hong Tseng

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng-Hong Tseng. A scholar is included among the top collaborators of Sheng-Hong Tseng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng-Hong Tseng. Sheng-Hong Tseng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Chen, Yun, Chuan Li, Ya‐Hui Tsai, & Sheng-Hong Tseng. (2017). Intestinal Crypt Organoid: Isolation of Intestinal Stem Cells, In Vitro Culture, and Optical Observation. Methods in molecular biology. 1576. 215–228. 4 indexed citations
3.
Kuo, Kuan‐Ting, Lu‐Ting Kuo, Yi‐Ting Lin, et al.. (2009). O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers. Lung Cancer. 68(3). 484–490. 25 indexed citations
4.
Chen, Yun, et al.. (2005). Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats. Cancer Immunology Immunotherapy. 55(7). 873–883. 8 indexed citations
5.
Tseng, Sheng-Hong, et al.. (2005). Induction of T-Cell Apoptosis in Rats by Genetically Engineered Glioma Cells Expressing Granulocyte-Macrophage Colony-Stimulating Factor and B7.1. Clinical Cancer Research. 11(4). 1639–1649. 4 indexed citations
6.
Tseng, Sheng-Hong, et al.. (2004). Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats. Clinical Cancer Research. 10(6). 2190–2202. 176 indexed citations
7.
Tseng, Sheng-Hong, et al.. (2003). Dural metastasis in patients with malignant neoplasm and chronic subdural hematoma. Acta Neurologica Scandinavica. 108(1). 43–46. 27 indexed citations
8.
Chen, Yun, King‐Jen Chang, Lih‐Hwa Hwang, Chiung‐Nien Chen, & Sheng-Hong Tseng. (2002). Establishment and characterization of a rectal cancer model in mice: application to cytokine gene therapy. International Journal of Colorectal Disease. 17(6). 388–395. 7 indexed citations
9.
Tseng, Sheng-Hong, et al.. (1999). Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain. Cancer Gene Therapy. 6(4). 302–312. 13 indexed citations
10.
Tseng, Sheng-Hong & Swei-Ming Lin. (1998). Substantia nigra lesion suppresses the antagonistic effects of N-methyl-d-aspartate receptor antagonist (MK-801) on the autotomy in the rat. Neuroscience Letters. 255(3). 167–171. 4 indexed citations
11.
Tseng, Sheng-Hong & Swei-Ming Lin. (1997). Surgical treatment of thoracic arachnoiditis with multiple subarachnoid cysts caused by epidural anesthesia. Clinical Neurology and Neurosurgery. 99(4). 256–258. 10 indexed citations
12.
Bobola, M S, et al.. (1996). Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin.. PubMed. 2(4). 735–41. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026